Global Opioids Market - Growth Drivers, Opportunities and Forecast Analysis to 2020-2026
Summary -
A new market
study, titled “Global Wireless Network Infrastr ucture Ecosystem Market Analysis,
Trends and Opportunities -2020-2026” has been featured on WiseGuyReports.
Opioids are drugs that act on the
nervous system to relieve pain. The term opioid refers to all substances
(exogenous or endogenous) with morphine-like properties. They are the most
widely prescribed medications to treat moderate to severe chronic pain. These
analgesics are used to manage pain in cancer patients and to treat severe
constant pain in patients who suffer from terminal illnesses.
The main purpose of opioids is to
treat conditions inducing chronic pain such as cancers, arthritis, lower back
pain, and fibromyalgia. The market for opioids is increasing due to the growing
geriatric population, coupled with an increasing focus on palliative care and
technological advancements in opioids. However, drug misuse and addiction are
likely to hamper the market growth over the forecast period.
The global opioids market is growing
at a rapid pace. The global opioids market is expected to reach USD 29,535.80
million by 2023 from USD 19,554.49 million in 2017 and is expected to register
a CAGR of 7.12% during the forecast period of 2018 to 2023.
In 2017, the market was led by the
Americas with a 77.49% share, followed by Europe, and Asia-Pacific with shares
of 10.69% and 8.1%, respectively.
The market has been segmented based
on product, application, and end-user.
The global opioids market on the
basis of product has been segmented into immediate-release/short-acting opioid
and extended-release/long-acting opioid. Immediate-release/short-acting opioid
is further sub-segmented into codeine, oxycodone, hydrocodone, fentanyl,
morphine, propoxyphene, and others. Extended-release/long-acting opioid is
further sub-segmented into oxycodone, hydrocodone, methadone, fentanyl,
morphine, oxymorphone, and others. The extended-release opioid segment
accounted for the larger market share of 65.21% in 2017, with a market value of
USD 12,750.91 million; it is expected to register a CAGR of 6.96% during the
forecast period.
The global opioids market on the
basis of application has been segmented into pain relief and anesthesia. Pain
relief is further sub-segmented into cancer pain, postoperative pain
management, low-back pain, orthopedic pain, neuropathic pain, and fibromyalgia.
Anesthesia is further sub-segmented into cough suppression, diarrhea
suppression, and de-addiction. The pain relief segment accounted for the
largest market share of 38.09% in 2017, with a market value of USD 7,448.51
million; it is expected to register a CAGR of 6.28% during the forecast period.
The global opioids market on the
basis of end user has been segmented into hospitals and clinics, pharmacies,
academic research institutes, and others. The hospitals and clinics segment
accounted for the largest market share of 50.51% in 2017, with a market value
of USD 9,876.99 million; it is expected to register a CAGR of 6.90% during the
forecast period.
Key Players
Sanofi SA, Pfizer Inc, Boehringer
Ingelheim GmbH, Teva Pharmaceutical Industries Ltd, Allergan Inc., Purdue
Pharma L.P., West-Ward Pharmaceuticals Corporation, Sun Pharmaceutical
Industries Ltd, Egalet Corporation, Janssen Global Services, LLC, Vertice Pharma
LLC, and Mallinckrodt
Study Objectives
To provide a detailed analysis of the
market structure along with a forecast of various segments and sub-segments of
the global opioids market
• To provide insights into factors
influencing and affecting the market growth
• To provide historical and forecast
revenue of market segments and sub-segments with respect to countries
• To provide strategic profiling of
key players in the market and comprehensively analyzing their market share,
core competencies, and drawing a competitive landscape for the market
• To provide economic factors that
influence the global opioids market
• To provide a detailed analysis of
the value chain and supply chain of the global opioids market
Target Audience
• Research and Development (R&D)
Companies
• Pharmaceutical Companies
• Government Research Institutes
• Academic Institutes and
Universities
• Research Laboratories
• Hospitals and Clinics
Key Findings
• The global opioids market is
expected to reach USD 29,535.80 million by 2023 at a CAGR of 7.12% from 2018 to
2023
• The Americas accounted for the
largest market share of 77.49% in 2017, with a market value of USD 15,151.87
million; the market is expected to register a CAGR of 6.72% during the forecast
period. Europe was the second-largest market in 2017, valued at USD 2,091.00
million; the market is projected to exhibit a CAGR of 7.34%. However, the
market in Asia-Pacific is expected to register the highest CAGR of 10.34%.
• On the basis of end user, the
hospitals and clinics segment accounted for the largest market share of 50.51%
in 2017, with a market value of USD 9,876.99 million; it is expected to
register a CAGR of 6.90% during the forecast period. The pharmacies segment was
the second-largest market in 2017, valued at USD 4,368.80 million; it is
projected to exhibit a CAGR of 7.31%. However, the academic research institutes
segment is expected to register the highest CAGR of 7.53%.
• On the basis of application, the
anesthesia segment was the second-largest market in 2017, valued at USD
4,082.84 million; the market is projected to register the highest CAGR of
7.94%.
Regional Analysis
• Americas
o North America
US
Canada
o Latin America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa
FOR MORE DETAILS:- https://www.wiseguyreports.com/reports/4255635-global-opioids-market-research-report-forecast-to-2023
About Us:
Wise Guy Reports is part of the Wise Guy Research
Consultants Pvt. Ltd. and offers premium progressive statistical surveying,
market research reports, analysis & forecast data for industries and
governments around the globe.
Contact Us:
NORAH
TRENT
Ph: +162-825-80070
(US)
Ph: +44 2035002763 (UK)
Comments
Post a Comment